Thompson Davis & Co., Inc. Celcuity Inc. Transaction History
Thompson Davis & Co., Inc.
- $132 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding CELC
# of Institutions
107Shares Held
30.3MCall Options Held
30.8KPut Options Held
152K-
Bvf Inc San Francisco, CA3.47MShares$48.2 Million1.64% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$32.8 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$26.1 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$22.6 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.54MShares$21.3 Million0.4% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $208M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...